Mirabella Financial Services LLP bought a new position in CME Group Inc. (NASDAQ:CME - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 9,705 shares of the financial services provider's stock, valued at approximately $2,252,000.
Several other hedge funds have also added to or reduced their stakes in the business. New Age Alpha Advisors LLC boosted its position in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after buying an additional 43 shares during the period. Avidian Wealth Enterprises LLC boosted its holdings in shares of CME Group by 2.6% during the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider's stock worth $411,000 after purchasing an additional 45 shares during the period. TFC Financial Management Inc. grew its stake in shares of CME Group by 8.4% in the fourth quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider's stock worth $137,000 after purchasing an additional 46 shares during the last quarter. Waldron Private Wealth LLC increased its holdings in CME Group by 2.0% during the 4th quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider's stock valued at $549,000 after purchasing an additional 47 shares during the period. Finally, Venturi Wealth Management LLC increased its holdings in CME Group by 12.1% during the 4th quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider's stock valued at $101,000 after purchasing an additional 47 shares during the period. 87.75% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the company. Morgan Stanley lifted their price objective on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research report on Thursday. Oppenheimer upped their price objective on shares of CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a report on Friday, April 11th. Erste Group Bank raised shares of CME Group to a "strong-buy" rating in a research note on Monday, March 17th. Raymond James upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a research report on Monday, March 10th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of "Hold" and an average price target of $248.93.
View Our Latest Stock Analysis on CME Group
CME Group Stock Up 0.7 %
CME Group stock traded up $1.79 during mid-day trading on Thursday, hitting $263.27. The company had a trading volume of 2,632,132 shares, compared to its average volume of 2,157,714. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $273.42. The company has a market capitalization of $94.87 billion, a PE ratio of 27.23, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. The stock's 50 day moving average price is $258.05 and its two-hundred day moving average price is $241.21. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were issued a dividend of $1.25 per share. This is a boost from CME Group's previous quarterly dividend of $1.15. The ex-dividend date was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.90%. CME Group's dividend payout ratio is presently 51.71%.
Insider Activity at CME Group
In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the completion of the sale, the insider now owns 27,046 shares of the company's stock, valued at $6,774,211.62. This represents a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock valued at $6,871,496 over the last 90 days. Corporate insiders own 0.30% of the company's stock.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.